From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...
Jul 20, 2026
0
5
The pendulum may have swung too far in the direction of caution when it comes to limiting opioids for adolescents who are in pain, according to new research from a University of Alberta emergency medicine team published in ...
Jul 20, 2026
0
4
Every year, the global pharmaceutical industry produces trillions of doses of medications. Manufacturing these drugs involves several stages, and the chance of contamination increases with every step.
Jul 20, 2026
0
3
There is no statistically significant evidence that taking acetaminophen, also known as Tylenol, during pregnancy negatively affects how early a child is born or a child's birth weight, according to new research led by environmental ...
Jul 20, 2026
0
2
A subanalysis of a single-group, open-label, Phase IIb study found that olorofim, a first-in-class orotomide antifungal agent that does not have U.S. FDA approval, showed efficacy in patients with disseminated coccidioidomycosis ...
Jul 20, 2026
0
1
For many cancer survivors, cannabis has become part of how they manage symptoms such as pain, nausea and anxiety. Medical cannabis is now legal in 47 states, Washington, D.C., and three U.S. territories, and its use continues ...
Jul 18, 2026
0
9
Scientists have identified genetic changes in wild populations of the parasitic worm that causes schistosomiasis that may reduce its response to praziquantel, the only available treatment. The study provides an early warning ...
Jul 17, 2026
0
6
Researchers at the University of California San Diego School of Medicine have reported results from a large international clinical trial showing that semaglutide, a medication in the GLP-1 class of drugs widely used to treat ...
Jul 17, 2026
0
8
Despite the end of federal shortages of popular GLP-1 weight-loss medications, the market for compounded alternatives remains strong—and some patients may unknowingly be receiving products from pharmacies with concerning ...
Jul 17, 2026
0
6
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of medication that mimics the GLP-1 hormone—to lower blood sugar and support weight loss. Some research ...
Jul 17, 2026
0
5
